Brief description and aims of work
Situated at the heart of Europe, the Jules Bordet Institute (Institut Jules Bordet) is one of Europe’s first ever cancer centres. Belgium’s only independent hospital dedicated entirely to cancer, Institut Jules Bordet’s multidisciplinary strategy encompasses its three key missions: patient care, research and teaching. Institut Jules Bordet brings together all the medical and paramedical disciplines at a single site, enabling it to provide the full range of cancer prevention, screening, diagnosis, treatment and rehabilitation services. The Institute is essentially a pioneer and innovator, ensuring that it always uses cutting-edge technology and the very latest therapeutic approaches, as well as those in development.
With a capacity of 154 hospital beds and 13 outpatient beds, the Institut Jules Bordet handles 6,000 hospital stays and 12,000 outpatient visits annually. It provides more than 70,000 consultations per year, including around 14,000 screenings. The Institute employs a staff of 900, including 150 doctors and 100 researchers. Its major translational, clinical and basic research activities result in an average of 200 top-level scientific articles per year. Institut Jules Bordet belongs to the academic research network of the “Université Libre de Bruxelles”. Institut Jules Bordet works with a number of European and American institutions, including the United States National Cancer Institute (NCI), the European Organisation for Research and Treatment of Cancer (EORTC) and the Organisation of European Cancer Institutes (OECI).
Institut Jules Bordet